Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.
Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.
J Neural Transm (Vienna). 2019 Apr;126(4):517-529. doi: 10.1007/s00702-019-01998-x. Epub 2019 Mar 28.
Attention-deficit hyperactivity disorder (ADHD) has been postulated to associate with dopaminergic dysfunction, including the dopamine transporter (DAT1). Several meta-analyses showed small but significant association between the 10-repeat allele in the DAT1 gene in 3'-untranslated region variant number tandem repeat polymorphism and child and adolescent ADHD, whereas in adult ADHD the 9-repeat allele was suggested to confer as risk allele. Interestingly, recent evidence indicated that the long-allele variants (10 repeats and longer) might confer to lower expression of the transporter in comparison to the short-allele. Therefore, we assessed here the association in samples consisting of families with child and adolescent ADHD as well as a case-control sample, using either the 10- versus 9-repeat or the long- versus short-allele approach. Following, we conducted a systematic review and meta-analysis, including family and case-control studies, using the two aforementioned approaches as well as stratifying to age and ethnicity. The first approach (10-repeat) resulted in nominal significant association in child and adolescent ADHD (OR 1.1050 p = 0.0128), that became significant stratifying to European population (OR 1.1301 p = 0.0085). The second approach (long-allele) resulted in significant association with the whole ADHD population (OR 1.1046 p = 0.0048), followed by significant association for child and adolescent ADHD (OR 1.1602 p = 0.0006) and in Caucasian and in European child and adolescent ADHD (OR 1.1310 p = 0.0114; OR 1.1661 p = 0.0061; respectively). We were not able to confirm the association reported in adults using both approaches. In conclusion, we found further indication for a possible DAT1 gene involvement; however, further studies should be conducted with stringent phenotyping to reduce heterogeneity, a limitation observed in most included studies.
注意缺陷多动障碍(ADHD)被认为与多巴胺能功能障碍有关,包括多巴胺转运体(DAT1)。几项荟萃分析显示,在多巴胺转运体基因 3'非翻译区变异数串联重复多态性的 10 重复等位基因与儿童和青少年 ADHD 之间存在微小但显著的关联,而在成人 ADHD 中,9 重复等位基因被认为是风险等位基因。有趣的是,最近的证据表明,长等位基因变异体(10 次重复及以上)可能与转运体的表达降低有关,而短等位基因则没有。因此,我们在这里评估了包含儿童和青少年 ADHD 患者家庭样本和病例对照样本的关联,使用 10 次重复与 9 次重复或长等位基因与短等位基因的方法。随后,我们进行了一项系统综述和荟萃分析,包括使用上述两种方法以及按年龄和种族分层的家族和病例对照研究。第一种方法(10 次重复)在儿童和青少年 ADHD 中导致名义上的显著关联(OR 1.1050,p=0.0128),在欧洲人群中分层后变得显著(OR 1.1301,p=0.0085)。第二种方法(长等位基因)与整个 ADHD 人群显著相关(OR 1.1046,p=0.0048),随后与儿童和青少年 ADHD 显著相关(OR 1.1602,p=0.0006),在白种人和欧洲儿童和青少年 ADHD 中也显著相关(OR 1.1310,p=0.0114;OR 1.1661,p=0.0061)。我们无法使用这两种方法证实成人中报道的关联。总之,我们发现了 DAT1 基因可能参与的进一步证据;然而,应该进行进一步的研究,使用严格的表型来减少异质性,这是大多数纳入研究的一个局限性。